Aberrant DNA methylation of P16, MGMT, hMLH1 and hMSH2 genes in combination with the MTHFR C677T genetic polymorphism in gastric cancer

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 5, 2013, Pages 3139-3142

  Xiong, Hai Lin ^a   Liu, Xun Qi ^a   Sun, Ai Hua ^a   He, Ying ^a   Li, Jun ^a   Xia, Yuan ^a  

^a HUIZHOU MUNICIPAL CENTRAL HOSPITAL   (China)

Author keywords

Aberrant DNA methylation; Gastric cancer; HMLH1; HMLH2; MGMT; P16

Indexed keywords

DNA METHYLTRANSFERASE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MGMT PROTEIN, HUMAN; MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; MTHFR PROTEIN, HUMAN; NUCLEAR PROTEIN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN MSH2; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CANCER STAGING; DNA METHYLATION; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROMOTER REGION; SQUAMOUS CELL CARCINOMA; STOMACH TUMOR; SURVIVAL RATE; TUMOR SUPPRESSOR GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; GENES, P16; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASM STAGING; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; PROGNOSIS; PROMOTER REGIONS, GENETIC; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84880381272     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.5.3139     Document Type: Article

References (20)

1. Aune D, Deneo-Pellegrini H, Ronco AL, et al (2011). Dietary folate intake and the risk of 11 types of cancer: a case-control study in Uruguay. Ann Oncol, 22, 444-51.
2. Bagley PJ, Selhub J (1998). A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc Natl Acad Sci U S A, 95, 13217-20.
3. Chen J, Huang ZJ, Duan YQ, et al (2012). Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism and folate intake in esophageal squamous cell carcinoma. Asian Pac J Cancer Prev, 13, 5303-6.
4. Cheng H, Lu M, Mao LJ, et al (2012). Relationships among MTHFR a1298c gene polymorphisms and methylation status of Dact1 gene in transitional cell carcinomas. Asian Pac J Cancer Prev, 13, 5069-74.
5. de Cássia Carvalho Barbosa R, da Costa DM, Cordeiro DE, et al (2012). Interaction of MTHFR C677T and A1298C, and MTR A2756G gene polymorphisms in breast cancer risk in a population in Northeast Brazil. Anticancer Res, 32, 4805-11.
6. Frosst P, Blom HJ, Milos R, et al (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet, 10, 111-3.
7. Gao S, Ding LH, Wang JW, et al (2013). Diet folate, DNA methylation and polymorphisms in methylenetetrahydrofolate reductase in association with the susceptibility to gastric cancer. Asian Pac J Cancer Prev, 14, 299-302.
8. Gius D, Bradbury CM, Sun L, et al (2005). The epigenome as a molecular marker and target. Cancer, 104, 1789-93.
9. Gomes MV, Toffoli LV, Arruda DW, et al (2012). Age-related changes in the global DNA methylation profile of leukocytes are linked to nutrition but are not associated with the MTHFR C677T genotype or to functional capacities. PLoS One, 7, e52570.
10. Götze T, Röcken C, Röhl FW, et al (2007). Gene polymorphisms of folate metabolizing enzymes and the risk of gastric cancer. Cancer Lett, 251, 228-36.
11. International Agency for Research on Cancer (2008). Globocan 2008: Stomach Cancer incidence, Mortality and Prevalence Worldwide in 2008. IARC.
12. International Agency for Research on Cancer (1994). IARC working group on the evaluation of carcinogenic risks to humans, schistosomes, liver flukes, Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans, vol 61. International Agency for Research on Cancer, Lyon. 1-241.
13. Issa JP, Garcia-Manero G, Giles FJ, et al (2004). Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies. Blood, 103, 1635-40.
14. Jones PA, Baylin SB (2007). The epigenomics of cancer. Cell, 128, 683-92.
15. Miao X, Xing D, Tan W, et al (2002). Susceptibility to gastric cardia adenocarcinoma and genetic polymorphism in methylenetetrahydrofolate reductase in an at-risk Chinese population. Cancer Epidemiol Biomarkers Prev, 11, 1454-8.
16. Neves Filho EH, Alves MK, Lima VP, et al (2010). MTHFR C677T polymorphism and differential methylation status in gastric cancer: an association with Helicobacter pylori infection. Virchows Arch, 457, 627-33.
17. Momparler RL, Bovenzi V (2000). DNA methylation and cancer. J Cell Physiol, 183, 145-54.
18. Sato F, Meltzer SJ (2006). CpG island hypermethylation in progression of esophageal and gastric cancer. Cancer, 106, 483-93.
19. Saberi S, Zendehdel K, Jahangiri S, et al (2012). Impact of methylenetetrahydrofolate reductase C677T polymorphism on the risk of gastric cancer and its interaction with Helicobacter pylori infection. Iran Biomed J, 16, 179-84.
20. Wang J, Sasco AJ, Fu C, et al (2008). Aberrant DNA Methylation of P16, MGMT, and hMLH1 Genes in Combination with MTHFR C677T Genetic Polymorphism in Esophageal Squamous Cell Carcinoma. Cancer Epidemiol Biomarkers Prev, 17, 118-25.